Xin Lang Cai Jing·2026-01-15 02:55Group 1 - The core viewpoint of the news is that Spring Medical has shown significant financial performance and trading activity, with a notable increase in revenue and net profit year-on-year [2][3] - On January 14, Spring Medical's stock rose by 1.18%, with a trading volume of 154 million yuan, and a net financing purchase of 1.73 million yuan, indicating strong investor interest [1] - As of January 14, the total margin balance for Spring Medical was 42.55 million yuan, with a financing balance of 42.22 million yuan, representing 0.55% of the circulating market value, which is at a high level compared to the past year [1] Group 2 - Spring Medical specializes in the research, production, and sales of implantable orthopedic medical devices, with its main products including joint prosthetics and spinal implants [2] - The company reported a revenue of 756 million yuan for the first nine months of 2025, reflecting a year-on-year growth of 48.75%, and a net profit of 192 million yuan, which is a 213.21% increase compared to the previous year [2] - The company has distributed a total of 440 million yuan in dividends since its A-share listing, with 390 million yuan distributed over the past three years [3]